U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with View All

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
137999 Q2 2022 ANHYDROUS CITRIC ACID BUCCAL FILM, SOLUBLE 3mg Correction
138000 Q3 2022 ANHYDROUS CITRIC ACID BUCCAL FILM, SOLUBLE 2mg Correction
138001 Q2 2022 BETADEX TOPICAL GEL 20mg Correction
138002 Q3 2022 BETADEX TOPICAL GEL 1.00 %w/w Correction
138003 Q2 2022 BUTYL ALCOHOL ORAL TABLET, EXTENDED RELEASE 0.02 mg Correction
138004 Q3 2022 BUTYL ALCOHOL ORAL TABLET, EXTENDED RELEASE NA Correction
138005 Q2 2022 CROSPOVIDONE ORAL TABLET, DELAYED RELEASE 280mg Correction
138006 Q3 2022 CROSPOVIDONE ORAL TABLET, DELAYED RELEASE 224mg Correction
138007 Q2 2022 DIBUTYL SEBACATE ORAL CAPSULE 20mg Correction
138008 Q3 2022 DIBUTYL SEBACATE ORAL CAPSULE 15mg Correction
138009 Q2 2022 EDETATE DISODIUM INTRAVENOUS LIQUID 0.05 %w/v Correction
138010 Q3 2022 EDETATE DISODIUM INTRAVENOUS LIQUID 0.03 %w/v Correction
138011 Q2 2022 FRUCTOSE ORAL TABLET 137.20 mg Correction
138012 Q3 2022 FRUCTOSE ORAL TABLET 64.92 mg Correction
138013 Q2 2022 GLYCERIN NASAL SPRAY, METERED 13mg Correction
138014 Q3 2022 GLYCERIN NASAL SPRAY, METERED 13mg Correction
138015 Q2 2022 HYDROXYPROPYL CELLULOSE ORAL TABLET, FILM COATED 30mg Correction
138016 Q3 2022 HYDROXYPROPYL CELLULOSE ORAL TABLET, FILM COATED 25mg Correction
138017 Q2 2022 METHYLPARABEN BUCCAL FILM, SOLUBLE 3mg Correction
138018 Q3 2022 METHYLPARABEN BUCCAL FILM, SOLUBLE 3mg Correction
138019 Q2 2022 POLYCARBOPHIL BUCCAL FILM 2mg Correction
138020 Q3 2022 POLYCARBOPHIL BUCCAL FILM 2mg Correction
138021 Q2 2022 POLYETHYLENE OXIDE 5000000 ORAL TABLET, EXTENDED RELEASE 284mg Correction
138022 Q3 2022 POLYETHYLENE OXIDE 5000000 ORAL TABLET, EXTENDED RELEASE 272mg Correction
138023 Q2 2022 SACCHARIN SODIUM ORAL TABLET 84mg Correction
138024 Q3 2022 SACCHARIN SODIUM ORAL TABLET 43mg Correction
138025 Q2 2022 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3mg Correction
138026 Q3 2022 SODIUM BENZOATE BUCCAL FILM, SOLUBLE 3mg Correction
138027 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 129mg Correction
138028 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 0.01 %w/v Correction
138029 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 1mg Correction
138030 Q2 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 0.35 %w/v Correction
138031 Q3 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 27mg Correction
138032 Q2 2022 SORBITAN MONOOLEATE TOPICAL GEL 1.00 %w/w Correction
138033 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg Correction
138034 Q2 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 75mg Correction
138035 Q3 2022 SORBITOL ORAL CAPSULE, LIQUID FILLED 51mg Correction
138036 Q2 2022 STARCH 1500, PREGELATINIZED BUCCAL TABLET 16.60 mg Correction
138037 Q3 2022 STARCH, CORN BUCCAL TABLET 9mg Correction
138038 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE 5785mg Correction
138039 Q3 2022 STARCH, CORN ORAL CAPSULE 5785mg Correction
138040 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
138041 Q3 2022 STARCH, CORN ORAL CAPSULE, COATED, EXTENDED RELEASE 19mg Correction
138042 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, DELAYED RELEASE 216mg Correction
138043 Q3 2022 STARCH, CORN ORAL CAPSULE, DELAYED RELEASE 216mg Correction
138044 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
138045 Q3 2022 STARCH, CORN ORAL CAPSULE, EXTENDED RELEASE 194mg Correction
138046 Q2 2022 STARCH 1500, PREGELATINIZED ORAL CONCENTRATE NA Correction
138047 Q3 2022 STARCH, CORN ORAL CONCENTRATE NA Correction
138048 Q2 2022 STARCH 1500, PREGELATINIZED ORAL DROPS NA Correction
138049 Q3 2022 STARCH, CORN ORAL DROPS NA Correction
138050 Q2 2022 STARCH 1500, PREGELATINIZED ORAL LIQUID, EXTENDED RELEASE 113mg Correction
138051 Q3 2022 STARCH, CORN ORAL LIQUID, EXTENDED RELEASE 113mg Correction
138052 Q2 2022 STARCH 1500, PREGELATINIZED ORAL PASTILLE NA Correction
138053 Q3 2022 STARCH, CORN ORAL PASTILLE NA Correction
138054 Q2 2022 STARCH 1500, PREGELATINIZED ORAL POWDER, FOR SUSPENSION 34mg Correction
138055 Q3 2022 STARCH, CORN ORAL POWDER, FOR SUSPENSION 34mg Correction
138056 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 72.50 mg/ 5.00 ml Correction
138057 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg Correction
138058 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS NA Correction
138059 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg Correction
138060 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET 1116mg Correction
138061 Q3 2022 STARCH, CORN ORAL TABLET 1116mg Correction
138062 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, CHEWABLE 180mg Correction
138063 Q3 2022 STARCH, CORN ORAL TABLET, CHEWABLE 180mg Correction
138064 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 285.00 mg Correction
138065 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg Correction
138066 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, DELAYED RELEASE 240mg Correction
138067 Q3 2022 STARCH, CORN ORAL TABLET, DELAYED RELEASE 240mg Correction
138068 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, EXTENDED RELEASE 184mg Correction
138069 Q3 2022 STARCH, CORN ORAL TABLET, EXTENDED RELEASE 184mg Correction
138070 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED 696mg Correction
138071 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED 696mg Correction
138072 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 74.30 mg Correction
138073 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg Correction
138074 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
138075 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING 100mg Correction
138076 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
138077 Q3 2022 STARCH, CORN ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 10mg Correction
138078 Q2 2022 STARCH 1500, PREGELATINIZED SUBLINGUAL TABLET 409mg Correction
138079 Q3 2022 STARCH, CORN SUBLINGUAL TABLET 409mg Correction
138080 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL INSERT 210.00 mg Correction
138081 Q3 2022 STARCH, CORN VAGINAL INSERT 4mg Correction
138082 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET 210.00 mg Correction
138083 Q3 2022 STARCH, CORN VAGINAL TABLET 300mg Correction
138084 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET, FILM COATED 8.00 mg Correction
138085 Q3 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8mg Correction
138086 Q3 2022 ACETYLTRIBUTYL CITRATE ORAL TABLET, COATED PARTICLES 18.70 mg 150mg Deletion
138087 Q3 2022 ANHYDROUS DIBASIC CALCIUM PHOSPHATE ORAL CAPSULE, DELAYED RELEASE 381.00 mg 381mg Deletion
138088 Q3 2022 BETADEX SULFOBUTYL ETHER SODIUM SUBCUTANEOUS INJECTION, SOLUTION 40.00 %w/v Deletion
138089 Q3 2022 CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL TABLET, EXTENDED RELEASE 175.00 mg 525mg Deletion
138090 Q3 2022 FLAVOR CHERRY FT-9496 ORAL SOLUTION 10.00 mg/ 5.00 ml 233mg Deletion
138091 Q3 2022 CITRIC ACID MONOHYDRATE NASAL AEROSOL, SPRAY 3.50 mg Deletion
138092 Q3 2022 COTTONSEED OIL NASAL AEROSOL, SPRAY 50.50 mg Deletion
138093 Q3 2022 CROSPOVIDONE ORAL TABLET, MULTILAYER, EXTENDED RELEASE 5.00 mg Deletion
138094 Q3 2022 D&C RED NO. 30 ALUMINUM LAKE ORAL TABLET, COATED PARTICLES 0.80 mg Deletion
138095 Q3 2022 D&C RED NO. 33 ORAL CAPSULE, DELAYED RELEASE NA Deletion
138096 Q3 2022 DIETHYL PHTHALATE ORAL CAPSULE, DELAYED RELEASE PELLETS 8.89 mg 9mg Deletion
138097 Q3 2022 DYE FDC BLUE NO. 40 HT LAKE ORAL CAPSULE 0.16 mg Deletion
138098 Q3 2022 DYE FDC BLUE NO. 40 HT LAKE ORAL TABLET 0.23 mg Deletion
138099 Q3 2022 EDETATE TRISODIUM INTRAVENOUS INJECTION 0.37 %w/v Deletion
138100 Q3 2022 FATTY ACID GLYCERIDES SUBLINGUAL SPRAY 0.96 mg Deletion
138101 Q3 2022 FERRIC OXIDE RED BUCCAL FILM, SOLUBLE 0.03 mg Deletion
138102 Q3 2022 FERRIC OXIDE RED ORAL TABLET, MULTILAYER, EXTENDED RELEASE 0.11 mg Deletion
138103 Q3 2022 FERRIC OXIDE YELLOW ORAL TABLET, MULTILAYER, EXTENDED RELEASE 1.96 mg Deletion
138104 Q3 2022 HYPROMELLOSE ORAL TABLET, MULTILAYER, EXTENDED RELEASE 8.40 mg Deletion
138105 Q3 2022 HYPROMELLOSE 2906 (4000 MPA.S) BUCCAL GUM, CHEWING 14.00 mg Deletion
138106 Q3 2022 HYPROMELLOSE 2910 (15 MPA.S) ORAL TABLET, COATED PARTICLES 42.50 mg 340mg Deletion
138107 Q3 2022 HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S) ORAL TABLET 19.83 mg Deletion
138108 Q3 2022 HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) ORAL TABLET, COATED PARTICLES 186.9 mg 1495mg Deletion
138109 Q3 2022 ICODEXTRIN ORAL POWDER, FOR SOLUTION 12.50 mg/ 5.00 ml Deletion
138110 Q3 2022 DEXTRIN ORAL SOLUTION 20.00 mg/ 5.00 ml 480mg Deletion
138111 Q3 2022 INK BLACK SW-9009 ORAL CAPSULE, EXTENDED RELEASE NA Deletion
138112 Q3 2022 LACTOSE MONOHYDRATE ORAL TABLET, COATED PARTICLES 150.00 mg Deletion
138113 Q3 2022 MANNITOL INTRAVENOUS LIQUID 4.05 %w/v Deletion
138114 Q3 2022 MEDIUM-CHAIN TRIGLYCERIDES SUBLINGUAL SPRAY 36.70 mg Deletion
138115 Q3 2022 OPADRY 03B82849 YELLOW ORAL TABLET 20.00 mg 40mg Deletion
138116 Q3 2022 OPASPRAY K-1-2275 YELLOW ORAL TABLET NA Deletion
138117 Q3 2022 OPASPRAY K-1-3197 GREEN ORAL TABLET 1.12 mg Deletion
138118 Q3 2022 PEPPERMINT OIL SUBLINGUAL SPRAY 0.34 mg Deletion
138119 Q3 2022 POLYETHYLENE GLYCOL 3350 ORAL TABLET, ORALLY DISINTEGRATING 1.01 mg Deletion
138120 Q3 2022 POLYETHYLENE GLYCOL 400 ORAL TABLET, COATED PARTICLES 12.50 mg 100mg Deletion
138121 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 2.80 mg Deletion
138122 Q3 2022 POLYETHYLENE OXIDE 200000 ORAL TABLET 173.99 mg 348mg Deletion
138123 Q3 2022 POLYSORBATE 20 NASAL AEROSOL, SPRAY 27.00 mg Deletion
138124 Q3 2022 POLYSTYRENE SULFONIC ACID ORAL TABLET 43.75 mg Deletion
138125 Q2 2022 PONCEAU 3R ORAL CAPSULE NA Deletion
138126 Q2 2022 PONCEAU 3R ORAL CAPSULE, EXTENDED RELEASE 0.04 mg Deletion
138127 Q2 2022 PONCEAU 3R ORAL SYRUP 0.01 mg/ 1.00 ml Deletion
138128 Q2 2022 PONCEAU 3R ORAL TABLET 117.20 mg Deletion
138129 Q2 2022 PONCEAU 3R ORAL TABLET, COATED 0.26 mg Deletion
138130 Q2 2022 PONCEAU 3R ORAL TABLET, EXTENDED RELEASE 0.30 mg Deletion
138131 Q2 2022 PONCEAU 3R ORAL WAFER 0.05 mg Deletion
138132 Q2 2022 PONCEAU 3R TOPICAL SHAMPOO 1.70 %w/w Deletion
138133 Q2 2022 PONCEAU 4R ORAL CAPSULE 0.01 mg Deletion
138134 Q2 2022 PONCEAU 4R ORAL TABLET 0.15 mg Deletion
138135 Q2 2022 PONCEAU XYLIDINE ORAL CAPSULE NA Deletion
138136 Q2 2022 PONCEAU XYLIDINE ORAL CAPSULE, EXTENDED RELEASE NA Deletion
138137 Q2 2022 PONCEAU XYLIDINE ORAL SOLUTION 0.05 mg/ 1.00 ml Deletion
138138 Q2 2022 PONCEAU XYLIDINE ORAL SYRUP 0.10 mg/ 1.00 ml Deletion
138139 Q2 2022 PONCEAU XYLIDINE ORAL TABLET 0.18 mg Deletion
138140 Q3 2022 POVIDONE K25 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 1.8 mg Deletion
138141 Q3 2022 POVIDONE K30 ORAL TABLET, COATED PARTICLES 3.70 mg 30mg Deletion
138142 Q3 2022 POVIDONE K90 ORAL TABLET, COATED PARTICLES 27.60 mg 221mg Deletion
138143 Q3 2022 SESAME OIL ORAL TABLET, COATED NA Deletion
138144 Q3 2022 SILICA DIMETHYL SILYLATE TRANSDERMAL SYSTEM 38.59 mg Deletion
138145 Q3 2022 SODIUM LAURYL SULFATE ORAL TABLET, MULTILAYER, EXTENDED RELEASE 42.50 mg 43mg Deletion
138146 Q3 2022 SODIUM PHOSPHATE, DIBASIC TOPICAL SOLUTION 0.50 %w/v Deletion
138147 Q3 2022 SORBITAN MONOLAURATE NASAL AEROSOL, SPRAY 22.90 mg Deletion
138148 Q3 2022 STEARIC ACID ORAL TABLET, COATED PARTICLES 5.00 mg 40mg Deletion
138149 Q3 2022 TERT-BUTYL ALCOHOL INTRAVENOUS INJECTION 0.03 %w/v Deletion
138150 Q3 2022 TERT-BUTYL ALCOHOL SUBCUTANEOUS INJECTION 0.03 %w/v Deletion
138151 Q3 2022 TITANIUM DIOXIDE ORAL TABLET, COATED PARTICLES 15.00 mg 120mg Deletion
138152 Q3 2022 TRISODIUM CITRATE DIHYDRATE INTRAVENOUS LIQUID 0.36 %w/v Deletion
138153 Q3 2022 TRISODIUM CITRATE DIHYDRATE NASAL AEROSOL, SPRAY 17.00 mg Deletion
138154 Q3 2022 VANILLIN ORAL TABLET, COATED PARTICLES 1.50 mg 12mg Deletion
138155 Q2 2022 .ALPHA.-TOCOPHEROL ORAL CAPSULE 5.00 mg MDE Replacement
138156 Q3 2022 .ALPHA.-TOCOPHEROL ORAL CAPSULE 16mg MDE Replacement
138157 Q2 2022 .ALPHA.-TOCOPHEROL, DL- ORAL TABLET, CHEWABLE 0.02 mg MDE Replacement
138158 Q3 2022 .ALPHA.-TOCOPHEROL, DL- ORAL TABLET, CHEWABLE 30mg MDE Replacement
138159 Q2 2022 ACETYLTRIBUTYL CITRATE ORAL TABLET 0.56 mg MDE Replacement
138160 Q3 2022 ACETYLTRIBUTYL CITRATE ORAL TABLET 150mg MDE Replacement
138161 Q2 2022 ACRYLIC ADHESIVE 788 TRANSDERMAL SYSTEM 44.91 mg MDE Replacement
138162 Q3 2022 ACRYLIC ADHESIVE 788 TRANSDERMAL SYSTEM 45mg MDE Replacement
138163 Q2 2022 ALCOHOL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 7960.00 mg MDE Replacement
138164 Q3 2022 ALCOHOL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 31840mg MDE Replacement
138165 Q2 2022 ANHYDROUS CITRIC ACID BUCCAL FILM 1.04 mg MDE Replacement
138166 Q3 2022 ANHYDROUS CITRIC ACID BUCCAL FILM 9mg MDE Replacement
138167 Q2 2022 ANHYDROUS CITRIC ACID ORAL PASTE 0.85 mg/ 1.00 ml MDE Replacement
138168 Q3 2022 ANHYDROUS CITRIC ACID ORAL PASTE 26mg MDE Replacement
138169 Q2 2022 ANHYDROUS CITRIC ACID TOPICAL CLOTH 4.20 mg MDE Replacement
138170 Q3 2022 ANHYDROUS CITRIC ACID TOPICAL CLOTH 4mg MDE Replacement
138171 Q2 2022 ANHYDROUS TRISODIUM CITRATE SUBLINGUAL FILM 1.34 mg MDE Replacement
138172 Q3 2022 ANHYDROUS TRISODIUM CITRATE SUBLINGUAL FILM 4mg MDE Replacement
138173 Q2 2022 ANISE ORAL SOLUTION 5.00 mg/ 5.00 ml MDE Replacement
138174 Q3 2022 ANISE ORAL SOLUTION 72mg MDE Replacement
138175 Q2 2022 BENZYL ALCOHOL INTRAVENOUS INJECTION, SOLUTION 180.00 mg MDE Replacement
138176 Q3 2022 BENZYL ALCOHOL INTRAVENOUS INJECTION, SOLUTION 400mg MDE Replacement
138177 Q2 2022 BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, SOLUTION 40.00 %w/v MDE Replacement
138178 Q3 2022 BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, SOLUTION 13333mg MDE Replacement
138179 Q2 2022 BLACK CURRANT ORAL SOLUTION 35.55 mg/ 5.00 ml MDE Replacement
138180 Q3 2022 BLACK CURRANT ORAL SOLUTION 213mg MDE Replacement
138181 Q2 2022 BUTYLATED HYDROXYTOLUENE TOPICAL GEL 0.10 %w/w MDE Replacement
138182 Q3 2022 BUTYLATED HYDROXYTOLUENE TOPICAL GEL 8mg MDE Replacement
138183 Q2 2022 CALCIUM ACETATE ORAL SYRUP 3.00 mg/ 5.00 ml MDE Replacement
138184 Q3 2022 CALCIUM ACETATE ORAL SYRUP 6mg MDE Replacement
138185 Q2 2022 CALCIUM STEARATE ORAL POWDER 30.00 mg MDE Replacement
138186 Q3 2022 CALCIUM STEARATE ORAL POWDER 600mg MDE Replacement
138187 Q2 2022 CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL CAPSULE 8.00 mg MDE Replacement
138188 Q3 2022 CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) ORAL CAPSULE 16mg MDE Replacement
138189 Q2 2022 CARBOXYMETHYLCELLULOSE CALCIUM ORAL TABLET 125.00 mg MDE Replacement
138190 Q3 2022 CARBOXYMETHYLCELLULOSE CALCIUM ORAL TABLET 505mg MDE Replacement
138191 Q2 2022 CARBOXYMETHYLCELLULOSE SODIUM ORAL PASTE 5.00 mg/ 1.00 ml MDE Replacement
138192 Q3 2022 CARBOXYMETHYLCELLULOSE SODIUM ORAL PASTE 150mg MDE Replacement
138193 Q2 2022 CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM ORAL SUSPENSION 1975 mg MDE Replacement
138194 Q3 2022 CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM ORAL SUSPENSION 71mg MDE Replacement
138195 Q2 2022 CHLOROBUTANOL NASAL SOLUTION 5.25 mg MDE Replacement
138196 Q3 2022 CHLOROBUTANOL NASAL SOLUTION 2mg MDE Replacement
138197 Q2 2022 CITRIC ACID MONOHYDRATE NASAL SPRAY, METERED 1.70 mg/ 1.00 ml MDE Replacement
138198 Q3 2022 CITRIC ACID MONOHYDRATE NASAL SPRAY, METERED 1mg MDE Replacement
138199 Q2 2022 CITRIC ACID MONOHYDRATE ORAL POWDER, FOR SOLUTION 315.00 mg MDE Replacement
138200 Q3 2022 CITRIC ACID MONOHYDRATE ORAL POWDER, FOR SOLUTION 315mg MDE Replacement
138201 Q2 2022 COMPRESSIBLE SUGAR ORAL POWDER, FOR SOLUTION 1851.94 mg/ 5.00 ml MDE Replacement
138202 Q3 2022 COMPRESSIBLE SUGAR ORAL POWDER, FOR SOLUTION 37039mg MDE Replacement
138203 Q2 2022 COTTONSEED OIL INTRAMUSCULAR INJECTION 87.46 %w/v MDE Replacement
138204 Q3 2022 COTTONSEED OIL INTRAMUSCULAR INJECTION 1084mg MDE Replacement
138205 Q2 2022 CROSCARMELLOSE SODIUM ORAL SUSPENSION 143.50 mg/ 5.00 ml MDE Replacement
138206 Q3 2022 CROSCARMELLOSE SODIUM ORAL SUSPENSION 150mg MDE Replacement
138207 Q2 2022 CROSPOVIDONE ORAL GRANULE, FOR SOLUTION 36.30 mg MDE Replacement
138208 Q3 2022 CROSPOVIDONE ORAL GRANULE, FOR SOLUTION 18mg MDE Replacement
138209 Q2 2022 CROSPOVIDONE ORAL GRANULE, FOR SUSPENSION 23.32 mg MDE Replacement
138210 Q3 2022 CROSPOVIDONE ORAL GRANULE, FOR SUSPENSION 47mg MDE Replacement
138211 Q2 2022 CYCLOMETHICONE 5 TOPICAL CREAM, AUGMENTED 13.00 %w/w MDE Replacement
138212 Q3 2022 CYCLOMETHICONE 5 TOPICAL CREAM, AUGMENTED 260mg MDE Replacement
138213 Q2 2022 CYSTEINE HYDROCHLORIDE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 25.00 mg MDE Replacement
138214 Q3 2022 CYSTEINE HYDROCHLORIDE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 100mg MDE Replacement
138215 Q2 2022 CYSTEINE HYDROCHLORIDE INTRAVENOUS SOLUTION 0.03 %w/v MDE Replacement
138216 Q3 2022 CYSTEINE HYDROCHLORIDE INTRAVENOUS SOLUTION 100mg MDE Replacement
138217 Q2 2022 D&C RED NO. 27 ORAL TABLET, DELAYED RELEASE 0.70 mg MDE Replacement
138218 Q3 2022 D&C RED NO. 27 ORAL TABLET, DELAYED RELEASE 1mg MDE Replacement
138219 Q2 2022 DEXTROSE MONOHYDRATE NASAL SPRAY, METERED 5.00 mg MDE Replacement
138220 Q3 2022 DEXTROSE MONOHYDRATE NASAL SPRAY, METERED 20mg MDE Replacement
138221 Q2 2022 DIACETYLATED MONOGLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 2.37 mg MDE Replacement
138222 Q3 2022 DIACETYLATED MONOGLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 8mg MDE Replacement
138223 Q2 2022 DIBASIC POTASSIUM PHOSPHATE ORAL SUSPENSION 1.00 mg/ 1.00 ml MDE Replacement
138224 Q3 2022 DIBASIC POTASSIUM PHOSPHATE ORAL SUSPENSION 24mg MDE Replacement
138225 Q2 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER ORAL SUSPENSION 85.00 mg/ 5.00 ml MDE Replacement
138226 Q3 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER ORAL SUSPENSION 255mg MDE Replacement
138227 Q2 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER ORAL TABLET, DELAYED RELEASE 2.16 mg MDE Replacement
138228 Q3 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER ORAL TABLET, DELAYED RELEASE 4mg MDE Replacement
138229 Q2 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER TRANSDERMAL SYSTEM 18.00 mg MDE Replacement
138230 Q3 2022 DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER TRANSDERMAL SYSTEM 18mg MDE Replacement
138231 Q2 2022 DYE ORANGE PB-2148 ORAL TABLET 0.16 mg MDE Replacement
138232 Q3 2022 DYE ORANGE PB-2148 ORAL TABLET 1mg MDE Replacement
138233 Q2 2022 EDETATE DISODIUM TOPICAL CREAM, AUGMENTED 0.10 %w/w MDE Replacement
138234 Q3 2022 EDETATE DISODIUM TOPICAL CREAM, AUGMENTED 2mg MDE Replacement
138235 Q2 2022 ETHYL VANILLIN ORAL PASTE 0.22 mg/ 1.00 ml MDE Replacement
138236 Q3 2022 ETHYL VANILLIN ORAL PASTE 7mg MDE Replacement
138237 Q2 2022 ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B ORAL GRANULE, FOR SUSPENSION 10.62 mg MDE Replacement
138238 Q3 2022 ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B ORAL GRANULE, FOR SUSPENSION 21mg MDE Replacement
138239 Q2 2022 ETHYLPARABEN ORAL POWDER, FOR SOLUTION 0.66 mg/ 5.00 ml MDE Replacement
138240 Q3 2022 ETHYLPARABEN ORAL POWDER, FOR SOLUTION 13mg MDE Replacement
138241 Q2 2022 FD&C BLUE NO. 1 SUBLINGUAL FILM NA MDE Replacement
138242 Q3 2022 FD&C BLUE NO. 1 SUBLINGUAL FILM 0.07 mg MDE Replacement
138243 Q2 2022 FD&C BLUE NO. 2 ORAL TABLET, FILM COATED 0.70 mg MDE Replacement
138244 Q3 2022 FD&C BLUE NO. 2 ORAL TABLET, FILM COATED 2mg MDE Replacement
138245 Q2 2022 FD&C YELLOW NO. 6 ORAL POWDER, FOR SUSPENSION 1.00 mg MDE Replacement
138246 Q3 2022 FD&C YELLOW NO. 6 ORAL POWDER, FOR SUSPENSION 6mg MDE Replacement
138247 Q2 2022 FLAVOR BANANA GIVAUDAN 85509 ORAL SUSPENSION 2.50 mg/ 5.00 ml MDE Replacement
138248 Q3 2022 FLAVOR BANANA GIVAUDAN 85509 ORAL SUSPENSION 10mg MDE Replacement
138249 Q2 2022 FLAVOR CHERRY 594 S.D. ORAL SOLUTION 2.00 mg/ 5.00 ml MDE Replacement
138250 Q3 2022 FLAVOR CHERRY 594 S.D. ORAL SOLUTION 40mg MDE Replacement
138251 Q2 2022 FLAVOR CHERRY 842 ORAL SOLUTION 24.72 mg/ 5.00 ml MDE Replacement
138252 Q3 2022 FLAVOR CHERRY 842 ORAL SOLUTION 356mg MDE Replacement
138253 Q2 2022 FLAVOR CHERRY PFC-9768 ORAL SUSPENSION 20.00 mg/ 1.00 ml MDE Replacement
138254 Q3 2022 FLAVOR CHERRY PFC-9768 ORAL SUSPENSION 480mg MDE Replacement
138255 Q2 2022 FLAVOR GRAPE 61.13252 ORAL SOLUTION 1.00 mg/ 5.00 ml MDE Replacement
138256 Q3 2022 FLAVOR GRAPE 61.13252 ORAL SOLUTION 20mg MDE Replacement
138257 Q2 2022 FLAVOR LEMON GIVAUDAN 74940-74 ORAL SUSPENSION 1.08 mg/ml MDE Replacement
138258 Q3 2022 FLAVOR LEMON GIVAUDAN 74940-74 ORAL SUSPENSION 43mg MDE Replacement
138259 Q2 2022 FLAVOR PEPPERMINT ART F-10012 ORAL SUSPENSION 0.50 mg/ 1.00 ml MDE Replacement
138260 Q3 2022 FLAVOR PEPPERMINT ART F-10012 ORAL SUSPENSION 12mg MDE Replacement
138261 Q2 2022 FLAVOR STRAWBERRY WD FO-1022 ORAL SOLUTION 15.00 mg/ 5.00 ml MDE Replacement
138262 Q3 2022 FLAVOR STRAWBERRY WD FO-1022 ORAL SOLUTION 30mg MDE Replacement
138263 Q2 2022 FLAVOR TUTTI FRUTTI PERMASEAL 77919-31 ORAL SOLUTION 0.50 mg/ 5.00 ml MDE Replacement
138264 Q3 2022 FLAVOR TUTTI FRUTTI PERMASEAL 77919-31 ORAL SOLUTION 1mg MDE Replacement
138265 Q2 2022 FRUCTOSE ORAL POWDER, FOR SUSPENSION 400.00 mg MDE Replacement
138266 Q3 2022 FRUCTOSE ORAL POWDER, FOR SUSPENSION 2400mg MDE Replacement
138267 Q2 2022 FUMARIC ACID ORAL SUSPENSION 5.00 mg/ 1.00 ml MDE Replacement
138268 Q3 2022 FUMARIC ACID ORAL SUSPENSION 120mg MDE Replacement
138269 Q2 2022 GELATIN SUBLINGUAL TABLET, ORALLY DISINTEGRATING 12.50 mg MDE Replacement
138270 Q3 2022 GELATIN SUBLINGUAL TABLET, ORALLY DISINTEGRATING 13mg MDE Replacement
138271 Q2 2022 GLYCERIN ORAL PASTE 127.40 mg/ 1.00 ml MDE Replacement
138272 Q3 2022 GLYCERIN ORAL PASTE 3822mg MDE Replacement
138273 Q2 2022 GLYCERIN TOPICAL CREAM, AUGMENTED 4.00 %w/w MDE Replacement
138274 Q3 2022 GLYCERIN TOPICAL CREAM, AUGMENTED 55mg MDE Replacement
138275 Q2 2022 GUAR GUM ORAL TABLET, EXTENDED RELEASE 24.00 mg MDE Replacement
138276 Q3 2022 GUAR GUM ORAL TABLET, EXTENDED RELEASE 24mg MDE Replacement
138277 Q2 2022 HYDROGENATED STARCH HYDROLYSATE SUBLINGUAL FILM 6.02 mg MDE Replacement
138278 Q3 2022 HYDROGENATED STARCH HYDROLYSATE SUBLINGUAL FILM 18mg MDE Replacement
138279 Q2 2022 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM 43.60 mg MDE Replacement
138280 Q3 2022 HYDROXYPROPYL CELLULOSE (1600000 WAMW) BUCCAL FILM 87mg MDE Replacement
138281 Q2 2022 HYPROMELLOSE 2910 (15 MPA.S) VAGINAL INSERT 36.76 mg MDE Replacement
138282 Q3 2022 HYPROMELLOSE 2910 (15 MPA.S) VAGINAL INSERT 37mg MDE Replacement
138283 Q2 2022 HYPROMELLOSE 2910 (4000 MPA.S) OPHTHALMIC SOLUTION 0.5 %w/v MDE Replacement
138284 Q3 2022 HYPROMELLOSE 2910 (4000 MPA.S) OPHTHALMIC SOLUTION 2mg MDE Replacement
138285 Q2 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL GRANULE 1.00 mg MDE Replacement
138286 Q3 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL GRANULE 18mg MDE Replacement
138287 Q2 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL POWDER, FOR SUSPENSION 35.00 mg/ 5.00 ml MDE Replacement
138288 Q3 2022 HYPROMELLOSE 2910 (6 MPA.S) ORAL POWDER, FOR SUSPENSION 504mg MDE Replacement
138289 Q2 2022 LACTOSE MONOHYDRATE ORAL GRANULE, FOR SOLUTION 1691.80 mg MDE Replacement
138290 Q3 2022 LACTOSE MONOHYDRATE ORAL GRANULE, FOR SOLUTION 846mg MDE Replacement
138291 Q2 2022 LACTOSE MONOHYDRATE ORAL TABLET, FOR SUSPENSION 543.60 mg MDE Replacement
138292 Q3 2022 LACTOSE MONOHYDRATE ORAL TABLET, FOR SUSPENSION 2794mg MDE Replacement
138293 Q2 2022 LECITHIN ORAL SUSPENSION 110.00 mg/ 1.00 ml MDE Replacement
138294 Q3 2022 LECITHIN ORAL SUSPENSION 150mg MDE Replacement
138295 Q2 2022 LIME OIL, COLD PRESSED ORAL LOZENGE 0.42 mg MDE Replacement
138296 Q3 2022 LIME OIL, COLD PRESSED ORAL LOZENGE 10mg MDE Replacement
138297 Q2 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, DELAYED RELEASE 30.99 mg MDE Replacement
138298 Q3 2022 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE ORAL TABLET, DELAYED RELEASE 103mg MDE Replacement
138299 Q2 2022 MAGNESIUM OXIDE ORAL TABLET, DELAYED RELEASE 367.86 mg MDE Replacement
138300 Q3 2022 MAGNESIUM OXIDE ORAL TABLET, DELAYED RELEASE 368mg MDE Replacement
138301 Q2 2022 MAGNESIUM STEARATE ORAL GRANULE, FOR SUSPENSION 7.00 mg MDE Replacement
138302 Q3 2022 MAGNESIUM STEARATE ORAL GRANULE, FOR SUSPENSION 14mg MDE Replacement
138303 Q2 2022 MALTODEXTRIN ORAL PASTE 35.00 mg/ 1.00 ml MDE Replacement
138304 Q3 2022 MALTODEXTRIN ORAL PASTE 1050mg MDE Replacement
138305 Q2 2022 MANNITOL INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 750 mg MDE Replacement
138306 Q3 2022 MANNITOL INTRAVENOUS INJECTION, POWDER, FOR SOLUTION 794mg MDE Replacement
138307 Q2 2022 MANNITOL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3850.00 mg MDE Replacement
138308 Q3 2022 MANNITOL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 15400mg MDE Replacement
138309 Q2 2022 MANNITOL INTRAVENOUS SOLUTION 4.15 %w/v MDE Replacement
138310 Q3 2022 MANNITOL INTRAVENOUS SOLUTION 15400mg MDE Replacement
138311 Q2 2022 MANNITOL ORAL POWDER 1100.00 mg MDE Replacement
138312 Q3 2022 MANNITOL ORAL POWDER 4663mg MDE Replacement
138313 Q2 2022 MANNITOL SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION 20 mg MDE Replacement
138314 Q3 2022 MANNITOL SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION 23mg MDE Replacement
138315 Q2 2022 MANNITOL SUBLINGUAL TABLET, ORALLY DISINTEGRATING 10.25 mg MDE Replacement
138316 Q3 2022 MANNITOL SUBLINGUAL TABLET, ORALLY DISINTEGRATING 10mg MDE Replacement
138317 Q2 2022 MEDIUM-CHAIN TRIGLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 3.08 mg MDE Replacement
138318 Q3 2022 MEDIUM-CHAIN TRIGLYCERIDES ORAL CAPSULE, EXTENDED RELEASE 5mg MDE Replacement
138319 Q2 2022 MENTHOL ORAL LOZENGE 0.94 mg MDE Replacement
138320 Q3 2022 MENTHOL ORAL LOZENGE 23mg MDE Replacement
138321 Q2 2022 MENTHOL SUBLINGUAL TABLET 2.00 mg MDE Replacement
138322 Q3 2022 MENTHOL SUBLINGUAL TABLET 2mg MDE Replacement
138323 Q2 2022 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 3.50 %w/w MDE Replacement
138324 Q3 2022 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 70mg MDE Replacement
138325 Q2 2022 METHYLPARABEN TOPICAL CREAM, AUGMENTED 0.20 %w/w MDE Replacement
138326 Q3 2022 METHYLPARABEN TOPICAL CREAM, AUGMENTED 2mg MDE Replacement
138327 Q2 2022 METHYLPARABEN SODIUM ORAL SOLUTION 2.60 mg/ 1.00 ml MDE Replacement
138328 Q3 2022 METHYLPARABEN SODIUM ORAL SOLUTION 104mg MDE Replacement
138329 Q2 2022 MONO AND DIGLYCERIDE TOPICAL CREAM 15.00 %w/w MDE Replacement
138330 Q3 2022 MONO AND DIGLYCERIDE TOPICAL CREAM 300mg MDE Replacement
138331 Q2 2022 OPADRY II 85F34610 PINK ORAL TABLET 4.00 mg MDE Replacement
138332 Q3 2022 OPADRY II 85F34610 PINK ORAL TABLET 8mg MDE Replacement
138333 Q2 2022 OPADRY II 85F48105 ORAL TABLET 1.50 mg MDE Replacement
138334 Q3 2022 OPADRY II 85F48105 ORAL TABLET 32mg MDE Replacement
138335 Q2 2022 OPADRY II YS-1-19025A CLEAR ORAL GRANULE, FOR SUSPENSION 7.08 mg MDE Replacement
138336 Q3 2022 OPADRY II YS-1-19025A CLEAR ORAL GRANULE, FOR SUSPENSION 14mg MDE Replacement
138337 Q2 2022 OPADRY OY-7300 WHITE ORAL TABLET 35.00 mg MDE Replacement
138338 Q3 2022 OPADRY OY-7300 WHITE ORAL TABLET 95mg MDE Replacement
138339 Q2 2022 OPADRY YELLOW ORAL TABLET, EXTENDED RELEASE 13.20 mg MDE Replacement
138340 Q3 2022 OPADRY YELLOW ORAL TABLET, EXTENDED RELEASE 47mg MDE Replacement
138341 Q2 2022 OPADRY YS-1-14129 PINK ORAL CAPSULE, EXTENDED RELEASE 9.00 mg MDE Replacement
138342 Q3 2022 OPADRY YS-1-14129 PINK ORAL CAPSULE, EXTENDED RELEASE 9mg MDE Replacement
138343 Q2 2022 OPADRY YS-3-7413 CLEAR ORAL TABLET, EXTENDED RELEASE 4.00 mg MDE Replacement
138344 Q3 2022 OPADRY YS-3-7413 CLEAR ORAL TABLET, EXTENDED RELEASE 35mg MDE Replacement
138345 Q2 2022 PARAFFIN ORAL TABLET, EXTENDED RELEASE 150.20 mg MDE Replacement
138346 Q3 2022 PARAFFIN ORAL TABLET, EXTENDED RELEASE 321mg MDE Replacement
138347 Q2 2022 PECTIN ORAL CAPSULE, EXTENDED RELEASE 5.447 mg MDE Replacement
138348 Q3 2022 PECTIN ORAL CAPSULE, EXTENDED RELEASE 5mg MDE Replacement
138349 Q2 2022 PEG-20 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 3.50 %w/w MDE Replacement
138350 Q3 2022 PEG-20 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 70mg MDE Replacement
138351 Q2 2022 PEPPERMINT OIL BUCCAL FILM 0.51 mg MDE Replacement
138352 Q3 2022 PEPPERMINT OIL BUCCAL FILM 1mg MDE Replacement
138353 Q2 2022 PHENOXYETHANOL TOPICAL CREAM, AUGMENTED 1.00 %w/w MDE Replacement
138354 Q3 2022 PHENOXYETHANOL TOPICAL CREAM, AUGMENTED 10mg MDE Replacement
138355 Q2 2022 POLOXAMER 124 TOPICAL GEL 0.20 %w/w MDE Replacement
138356 Q3 2022 POLOXAMER 124 TOPICAL GEL 6mg MDE Replacement
138357 Q2 2022 POLOXAMER 188 ORAL POWDER, FOR SOLUTION 25.00 mg/ 5.00 ml MDE Replacement
138358 Q3 2022 POLOXAMER 188 ORAL POWDER, FOR SOLUTION 500mg MDE Replacement
138359 Q2 2022 POLOXAMER 188 ORAL TABLET, FILM COATED 16.20 mg MDE Replacement
138360 Q3 2022 POLOXAMER 188 ORAL TABLET, FILM COATED 93mg MDE Replacement
138361 Q2 2022 POLOXAMER 407 ORAL TABLET 110.00 mg MDE Replacement
138362 Q3 2022 POLOXAMER 407 ORAL TABLET 495mg MDE Replacement
138363 Q2 2022 POLYETHYLENE GLYCOL 1450 ORAL CAPSULE, EXTENDED RELEASE 17.00 mg MDE Replacement
138364 Q3 2022 POLYETHYLENE GLYCOL 1450 ORAL CAPSULE, EXTENDED RELEASE 91mg MDE Replacement
138365 Q2 2022 POLYETHYLENE GLYCOL 1450 TOPICAL OINTMENT 43.00 %w/w MDE Replacement
138366 Q3 2022 POLYETHYLENE GLYCOL 1450 TOPICAL OINTMENT 921mg MDE Replacement
138367 Q2 2022 POLYETHYLENE GLYCOL 300 INTRAMUSCULAR SOLUTION 56.40 %w/v MDE Replacement
138368 Q3 2022 POLYETHYLENE GLYCOL 300 INTRAMUSCULAR SOLUTION 16920mg MDE Replacement
138369 Q2 2022 POLYETHYLENE GLYCOL 300 INTRAVENOUS SOLUTION 56.40 %w/v MDE Replacement
138370 Q3 2022 POLYETHYLENE GLYCOL 300 INTRAVENOUS SOLUTION 16920mg MDE Replacement
138371 Q2 2022 POLYETHYLENE GLYCOL 300 TOPICAL OINTMENT 57.00 %w/w MDE Replacement
138372 Q3 2022 POLYETHYLENE GLYCOL 300 TOPICAL OINTMENT 1114mg MDE Replacement
138373 Q2 2022 POLYETHYLENE GLYCOL 4000 ORAL SOLUTION 66.67 mg/ 1.00 ml MDE Replacement
138374 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL SOLUTION 2667mg MDE Replacement
138375 Q2 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, DELAYED RELEASE 1.00 mg MDE Replacement
138376 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, DELAYED RELEASE 2mg MDE Replacement
138377 Q2 2022 POLYETHYLENE GLYCOL 4500 ORAL CAPSULE, EXTENDED RELEASE 10.00 mg MDE Replacement
138378 Q3 2022 POLYETHYLENE GLYCOL 4500 ORAL CAPSULE, EXTENDED RELEASE 53mg MDE Replacement
138379 Q2 2022 POLYISOBUTYLENE (1100000 MW) TRANSDERMAL SYSTEM 22.65 mg MDE Replacement
138380 Q3 2022 POLYISOBUTYLENE (1100000 MW) TRANSDERMAL SYSTEM 23mg MDE Replacement
138381 Q2 2022 POLYSORBATE 20 ORAL SUSPENSION 5.00 mg/ 1.00 ml MDE Replacement
138382 Q3 2022 POLYSORBATE 20 ORAL SUSPENSION 21mg MDE Replacement
138383 Q2 2022 POLYSORBATE 80 ORAL PASTE 0.92 mg/ 1.00 ml MDE Replacement
138384 Q3 2022 POLYSORBATE 80 ORAL PASTE 28mg MDE Replacement
138385 Q2 2022 POLYSORBATE 80 ORAL TABLET, EXTENDED RELEASE 8.00 mg MDE Replacement
138386 Q3 2022 POLYSORBATE 80 ORAL TABLET, EXTENDED RELEASE 8mg MDE Replacement
138387 Q2 2022 POLYSORBATE 80 RECTAL SOLUTION 0.10 %w/v MDE Replacement
138388 Q3 2022 POLYSORBATE 80 RECTAL SOLUTION 840mg MDE Replacement
138389 Q2 2022 POTASSIUM BICARBONATE ORAL POWDER, FOR SOLUTION 500.00 mg MDE Replacement
138390 Q3 2022 POTASSIUM BICARBONATE ORAL POWDER, FOR SOLUTION 1000mg MDE Replacement
138391 Q2 2022 POTASSIUM CARBONATE ORAL TABLET 25.00 mg MDE Replacement
138392 Q3 2022 POTASSIUM CARBONATE ORAL TABLET 60mg MDE Replacement
138393 Q2 2022 POTASSIUM SORBATE ORAL PASTE 1.60 mg/ 1.00 ml MDE Replacement
138394 Q3 2022 POTASSIUM SORBATE ORAL PASTE 48mg MDE Replacement
138395 Q2 2022 POTASSIUM SORBATE ORAL SUSPENSION 485 mg MDE Replacement
138396 Q3 2022 POTASSIUM SORBATE ORAL SUSPENSION 17ng MDE Replacement
138397 Q2 2022 POVIDONE K25 ORAL TABLET, FILM COATED 54.47 mg MDE Replacement
138398 Q3 2022 POVIDONE K25 ORAL TABLET, FILM COATED 163mg MDE Replacement
138399 Q2 2022 POVIDONE K30 ORAL CAPSULE, COATED, EXTENDED RELEASE 15.2 mg MDE Replacement
138400 Q3 2022 POVIDONE K30 ORAL CAPSULE, COATED, EXTENDED RELEASE 15mg MDE Replacement
138401 Q2 2022 POWDERED CELLULOSE ORAL SUSPENSION 100.00 mg/ 5.00 ml MDE Replacement
138402 Q3 2022 POWDERED CELLULOSE ORAL SUSPENSION 400mg MDE Replacement
138403 Q2 2022 PROPYLPARABEN TOPICAL CREAM, AUGMENTED 0.10 %w/w MDE Replacement
138404 Q3 2022 PROPYLPARABEN TOPICAL CREAM, AUGMENTED 2mg MDE Replacement
138405 Q2 2022 PROSOLV SMCC HD 90 ORAL TABLET, DELAYED RELEASE 195.37 mg MDE Replacement
138406 Q3 2022 PROSOLV SMCC HD 90 ORAL TABLET, DELAYED RELEASE 195mg MDE Replacement
138407 Q2 2022 PROSOLV SMCC HD 90 ORAL TABLET, FILM COATED 375.52 mg MDE Replacement
138408 Q3 2022 PROSOLV SMCC HD 90 ORAL TABLET, FILM COATED 376mg MDE Replacement
138409 Q2 2022 SACCHARIN SODIUM ORAL GRANULE, FOR SOLUTION 5.50 mg MDE Replacement
138410 Q3 2022 SACCHARIN SODIUM ORAL GRANULE, FOR SOLUTION 3mg MDE Replacement
138411 Q2 2022 SACCHARIN SODIUM ORAL PASTE 0.08 mg/ 1.00 ml MDE Replacement
138412 Q3 2022 SACCHARIN SODIUM ORAL PASTE 3mg MDE Replacement
138413 Q2 2022 SCOTCHPAK 1022 TRANSDERMAL FILM, EXTENDED RELEASE 904.92 mg MDE Replacement
138414 Q3 2022 SCOTCHPAK 1022 TRANSDERMAL FILM, EXTENDED RELEASE 2335mg MDE Replacement
138415 Q2 2022 SILICON DIOXIDE ORAL CAPSULE, EXTENDED RELEASE 106.00 mg MDE Replacement
138416 Q3 2022 SILICON DIOXIDE ORAL CAPSULE, EXTENDED RELEASE 168mg MDE Replacement
138417 Q2 2022 SILICON DIOXIDE ORAL GRANULE, FOR SOLUTION 1.80 mg MDE Replacement
138418 Q3 2022 SILICON DIOXIDE ORAL GRANULE, FOR SOLUTION 3mg MDE Replacement
138419 Q2 2022 SILICON DIOXIDE ORAL POWDER 100.00 mg MDE Replacement
138420 Q3 2022 SILICON DIOXIDE ORAL POWDER 602mg MDE Replacement
138421 Q2 2022 SIMETHICONE ORAL POWDER, FOR SOLUTION 0.40 mg/ 5.00 ml MDE Replacement
138422 Q3 2022 SIMETHICONE ORAL POWDER, FOR SOLUTION 8mg MDE Replacement
138423 Q2 2022 SIMETHICONE EMULSION ORAL PASTE 1.80 mg/ 1.00 ml MDE Replacement
138424 Q3 2022 SIMETHICONE EMULSION ORAL PASTE 54mg MDE Replacement
138425 Q2 2022 SIMETHICONE EMULSION ORAL SOLUTION 0.08 mg/ 5.00 ml MDE Replacement
138426 Q3 2022 SIMETHICONE EMULSION ORAL SOLUTION 2mg MDE Replacement
138427 Q2 2022 SIMETHICONE EMULSION ORAL SUSPENSION 350 mg MDE Replacement
138428 Q3 2022 SIMETHICONE EMULSION ORAL SUSPENSION 13mg MDE Replacement
138429 Q2 2022 SODIUM BENZOATE ORAL PASTE 0.92 mg/ 1.00 ml MDE Replacement
138430 Q3 2022 SODIUM BENZOATE ORAL PASTE 28mg MDE Replacement
138431 Q2 2022 SODIUM BENZOATE ORAL POWDER, FOR SOLUTION 98.00 mg MDE Replacement
138432 Q3 2022 SODIUM BENZOATE ORAL POWDER, FOR SOLUTION 98mg MDE Replacement
138433 Q2 2022 SODIUM BENZOATE ORAL SOLUTION 330.00 mg MDE Replacement
138434 Q3 2022 SODIUM BENZOATE ORAL SOLUTION 660mg MDE Replacement
138435 Q2 2022 SODIUM BICARBONATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 573.50 mg MDE Replacement
138436 Q3 2022 SODIUM BICARBONATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3059mg MDE Replacement
138437 Q2 2022 SODIUM BISULFITE ORAL SUSPENSION 2.00 mg/ 5.00 ml MDE Replacement
138438 Q3 2022 SODIUM BISULFITE ORAL SUSPENSION 5mg MDE Replacement
138439 Q2 2022 SODIUM CHLORIDE INTRAVENOUS SOLUTION 9.00 mg MDE Replacement
138440 Q3 2022 SODIUM CHLORIDE INTRAVENOUS SOLUTION 90mg MDE Replacement
138441 Q2 2022 SODIUM CHLORIDE SUBMUCOSAL INJECTION 0.16 %w/v MDE Replacement
138442 Q3 2022 SODIUM CHLORIDE SUBMUCOSAL INJECTION 17mg MDE Replacement
138443 Q2 2022 SODIUM HYDROXIDE ORAL TABLET, FILM COATED 1.50 mg MDE Replacement
138444 Q3 2022 SODIUM HYDROXIDE ORAL TABLET, FILM COATED 8mg MDE Replacement
138445 Q2 2022 SODIUM LAURYL SULFATE ORAL TABLET, FOR SUSPENSION 48.00 mg MDE Replacement
138446 Q3 2022 SODIUM LAURYL SULFATE ORAL TABLET, FOR SUSPENSION 264mg MDE Replacement
138447 Q2 2022 SODIUM METABISULFITE SUBMUCOSAL INJECTION 0.05 %w/v MDE Replacement
138448 Q3 2022 SODIUM METABISULFITE SUBMUCOSAL INJECTION 5mg MDE Replacement
138449 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 0.32 %w/v MDE Replacement
138450 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTABLE, LIPOSOMAL 129mg MDE Replacement
138451 Q2 2022 SODIUM N-(MPEG 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 0.01 %w/v MDE Replacement
138452 Q3 2022 SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE INTRAVENOUS INJECTION 1mg MDE Replacement
138453 Q2 2022 SODIUM PHOSPHATE, DIBASIC INTRAVENOUS SOLUTION 0.01 %w/v MDE Replacement
138454 Q3 2022 SODIUM PHOSPHATE, DIBASIC INTRAVENOUS SOLUTION 52mg MDE Replacement
138455 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION 0.24 %w/v MDE Replacement
138456 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION 55mg MDE Replacement
138457 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.04 %w/v MDE Replacement
138458 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3mg MDE Replacement
138459 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE NASAL SPRAY 3.00 mg/ 1.00 ml MDE Replacement
138460 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE NASAL SPRAY 12mg MDE Replacement
138461 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.04 %w/v MDE Replacement
138462 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DIHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 3mg MDE Replacement
138463 Q2 2022 SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE NASAL SPRAY 6.64 mg/ 1.00 ml MDE Replacement
138464 Q3 2022 SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE NASAL SPRAY 7mg MDE Replacement
138465 Q2 2022 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE OPHTHALMIC SOLUTION/ DROPS 0.55 %w/v MDE Replacement
138466 Q3 2022 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE OPHTHALMIC SOLUTION/ DROPS 43mg MDE Replacement
138467 Q2 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 0.35 %w/v MDE Replacement
138468 Q3 2022 SODIUM PHOSPHATE, MONOBASIC INTRAVENOUS INJECTION, SOLUTION 27mg MDE Replacement
138469 Q2 2022 SODIUM PHOSPHATE, MONOBASIC ORAL TABLET 1.38 mg MDE Replacement
138470 Q3 2022 SODIUM PHOSPHATE, MONOBASIC ORAL TABLET 1mg MDE Replacement
138471 Q2 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE ORAL SUSPENSION 2225 mg MDE Replacement
138472 Q3 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE ORAL SUSPENSION 80mg MDE Replacement
138473 Q2 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 0.64 mg MDE Replacement
138474 Q3 2022 SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2mg MDE Replacement
138475 Q2 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, FOR SUSPENSION 30.00 mg MDE Replacement
138476 Q3 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, FOR SUSPENSION 165mg MDE Replacement
138477 Q2 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, ORALLY DISINTEGRATING 71.43 mg MDE Replacement
138478 Q3 2022 SODIUM STARCH GLYCOLATE TYPE A ORAL TABLET, ORALLY DISINTEGRATING 29mg MDE Replacement
138479 Q2 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE 15.00 mg MDE Replacement
138480 Q3 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE 180mg MDE Replacement
138481 Q2 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE, EXTENDED RELEASE 7.00 mg MDE Replacement
138482 Q3 2022 SODIUM STEARYL FUMARATE ORAL CAPSULE, EXTENDED RELEASE 11mg MDE Replacement
138483 Q2 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 18.20 mg MDE Replacement
138484 Q2 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 18.20 mg MDE Replacement
138485 Q3 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 1mg MDE Replacement
138486 Q3 2022 SODIUM STEARYL FUMARATE ORAL GRANULE, FOR SOLUTION 9mg MDE Replacement
138487 Q2 2022 SODIUM THIOSULFATE INTRAVENOUS INJECTION 4.00 mg MDE Replacement
138488 Q3 2022 SODIUM THIOSULFATE INTRAVENOUS INJECTION 18mg MDE Replacement
138489 Q2 2022 SORBITAN MONOOLEATE TOPICAL GEL 1.00 %w/w MDE Replacement
138490 Q3 2022 SORBITAN MONOOLEATE TOPICAL GEL 6mg MDE Replacement
138491 Q2 2022 SORBITOL INTRAVENOUS INJECTION, SOLUTION 30.00 %w/v MDE Replacement
138492 Q3 2022 SORBITOL INTRAVENOUS INJECTION, SOLUTION 3000mg MDE Replacement
138493 Q2 2022 SORBITOL NASAL SPRAY 6.17 mg/ 1.00 ml MDE Replacement
138494 Q3 2022 SORBITOL NASAL SPRAY 49mg MDE Replacement
138495 Q2 2022 SORBITOL SOLUTION ORAL SUSPENSION 35430 mg MDE Replacement
138496 Q3 2022 SORBITOL SOLUTION ORAL SUSPENSION 1275mg MDE Replacement
138497 Q2 2022 SQUALANE TOPICAL CREAM, AUGMENTED 6.00 %w/w MDE Replacement
138498 Q3 2022 SQUALANE TOPICAL CREAM, AUGMENTED 120mg MDE Replacement
138499 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION 72.50 mg/ 5.00 ml MDE Replacement
138500 Q3 2022 STARCH, CORN ORAL SUSPENSION 900mg MDE Replacement
138501 Q2 2022 STARCH 1500, PREGELATINIZED ORAL SUSPENSION/ DROPS NA MDE Replacement
138502 Q3 2022 STARCH, CORN ORAL SUSPENSION/ DROPS 90mg MDE Replacement
138503 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, COATED 285.00 mg MDE Replacement
138504 Q3 2022 STARCH, CORN ORAL TABLET, COATED 256mg MDE Replacement
138505 Q2 2022 STARCH 1500, PREGELATINIZED ORAL TABLET, FILM COATED, EXTENDED RELEASE 74.30 mg MDE Replacement
138506 Q3 2022 STARCH, CORN ORAL TABLET, FILM COATED, EXTENDED RELEASE 149mg MDE Replacement
138507 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET 210.00 mg MDE Replacement
138508 Q3 2022 STARCH, CORN VAGINAL TABLET 300mg MDE Replacement
138509 Q2 2022 STARCH 1500, PREGELATINIZED VAGINAL TABLET, FILM COATED 8.00 mg MDE Replacement
138510 Q3 2022 STARCH, CORN VAGINAL TABLET, FILM COATED 8mg MDE Replacement
138511 Q2 2022 STEARIC ACID ORAL CAPSULE, EXTENDED RELEASE 25.50 mg MDE Replacement
138512 Q3 2022 STEARIC ACID ORAL CAPSULE, EXTENDED RELEASE 64mg MDE Replacement
138513 Q2 2022 STEAROYL POLYOXYLGLYCERIDES ORAL CAPSULE 480.00 mg MDE Replacement
138514 Q3 2022 STEAROYL POLYOXYLGLYCERIDES ORAL CAPSULE 960mg MDE Replacement
138515 Q2 2022 STRAWBERRY ORAL SUSPENSION 0.70 mg/ 1.00 ml MDE Replacement
138516 Q3 2022 STRAWBERRY ORAL SUSPENSION 21mg MDE Replacement
138517 Q2 2022 SUCRALOSE NASAL SPRAY, METERED 1.50 mg/ 1.00 ml MDE Replacement
138518 Q3 2022 SUCRALOSE NASAL SPRAY, METERED 12mg MDE Replacement
138519 Q2 2022 SUCROSE ORAL CAPSULE, COATED, EXTENDED RELEASE 86.01 mg MDE Replacement
138520 Q3 2022 SUCROSE ORAL CAPSULE, COATED, EXTENDED RELEASE 86mg MDE Replacement
138521 Q2 2022 SUCROSE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 4.25 %w/v MDE Replacement
138522 Q3 2022 SUCROSE SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 308mg MDE Replacement
138523 Q2 2022 SUCROSE STEARATE ORAL TABLET, EXTENDED RELEASE 44.56 mg MDE Replacement
138524 Q3 2022 SUCROSE STEARATE ORAL TABLET, EXTENDED RELEASE 57mg MDE Replacement
138525 Q2 2022 TALC ORAL CAPSULE, COATED, EXTENDED RELEASE 20.35 mg MDE Replacement
138526 Q3 2022 TALC ORAL CAPSULE, COATED, EXTENDED RELEASE 20mg MDE Replacement
138527 Q2 2022 TITANIUM DIOXIDE BUCCAL FILM 1.66 mg MDE Replacement
138528 Q3 2022 TITANIUM DIOXIDE BUCCAL FILM 3mg MDE Replacement
138529 Q2 2022 TITANIUM DIOXIDE ORAL CAPSULE 74.20 mg MDE Replacement
138530 Q3 2022 TITANIUM DIOXIDE ORAL CAPSULE 4mg MDE Replacement
138531 Q2 2022 TRIETHYL CITRATE ORAL CAPSULE, COATED, EXTENDED RELEASE 7.09 mg MDE Replacement
138532 Q3 2022 TRIETHYL CITRATE ORAL CAPSULE, COATED, EXTENDED RELEASE 7mg MDE Replacement
138533 Q2 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) TRANSDERMAL SYSTEM 44.51 mg MDE Replacement
138534 Q3 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) TRANSDERMAL SYSTEM 45mg MDE Replacement
138535 Q2 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) TRANSDERMAL FILM, EXTENDED RELEASE 228.23 mg MDE Replacement
138536 Q3 2022 TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) TRANSDERMAL FILM, EXTENDED RELEASE 704mg MDE Replacement
138537 Q2 2022 TRISODIUM CITRATE DIHYDRATE TOPICAL CLOTH 1.68 mg MDE Replacement
138538 Q3 2022 TRISODIUM CITRATE DIHYDRATE TOPICAL CLOTH 2mg MDE Replacement
138539 Q2 2022 TROLAMINE TOPICAL CREAM, AUGMENTED 1.00 %w/w MDE Replacement
138540 Q3 2022 TROLAMINE TOPICAL CREAM, AUGMENTED 20mg MDE Replacement
138541 Q2 2022 TROMETHAMINE INTRAVENOUS INJECTION, SOLUTION 1.21 %w/v MDE Replacement
138542 Q3 2022 TROMETHAMINE INTRAVENOUS INJECTION, SOLUTION 300mg MDE Replacement
138543 Q2 2022 VEGETABLE OIL GLYCERIDE, HYDROGENATED ORAL TABLET, EXTENDED RELEASE 35 mg MDE Replacement
138544 Q3 2022 VEGETABLE OIL GLYCERIDE, HYDROGENATED ORAL TABLET, EXTENDED RELEASE 77mg MDE Replacement
138545 Q2 2022 VEGETABLE OIL, HYDROGENATED ORAL CAPSULE 261.00 mg MDE Replacement
138546 Q3 2022 VEGETABLE OIL, HYDROGENATED ORAL CAPSULE 311mg MDE Replacement
138547 Q2 2022 WHITE WAX ORAL CAPSULE, EXTENDED RELEASE 15.30 mg MDE Replacement
138548 Q3 2022 WHITE WAX ORAL CAPSULE, EXTENDED RELEASE 71mg MDE Replacement
138549 Q2 2022 XANTHAN GUM ORAL PASTE 35.00 mg/ 1.00 ml MDE Replacement
138550 Q3 2022 XANTHAN GUM ORAL PASTE 1050mg MDE Replacement
138551 Q2 2022 XYLITOL ORAL PASTE 6.00 mg/ 1.00 ml MDE Replacement
138552 Q3 2022 XYLITOL ORAL PASTE 180mg MDE Replacement
138553 Q2 2022 YELLOW WAX ORAL CAPSULE 16.80 mg MDE Replacement
138554 Q3 2022 YELLOW WAX ORAL CAPSULE 40mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top